Measles Vaccine

Measles Vaccine is a freeze-dried preparation of a suitable live attenuated strain of measles virus grown in cultures of chick embryo cells or human diploid cells. Measles Vaccine is used to provide active immunization against infection from measles. Measles Vaccine is recommended for children 15 months of age and older and adults.


Adult Dose
Dose: 0.5 ml
Single Dose: 0.5 (0.5)
Frequency: As recommended.
Route: SC, IM
Instructions: For all childrens from the age of 9 months.
Neonatal
Dose: 0.5 ml
Single Dose: 0.5 (0.5)
Frequency: As recommended.
Route: Subcutaneous
Instructions: For Once
Paedriatic
Dose: 0.5 ml
Single Dose: 0.5 (0.5)
Frequency: As recommended.
Route: Subcutaneous
Instructions: For Once
Characteristics
It belongs to Toxoids and Vaccines pharmacological group.
Contraindications
Measles Vaccine is contraindicated in conditions like Anaphylactic reactions,Respiratory tract infections,Tuberculosis,AIDS.
Effects
The severe or irreversible adverse effects of Measles Vaccine, which give rise to further complications include Convulsions.Measles Vaccine produces potentially life-threatening effects which include Thrombocytopenia. which are responsible for the discontinuation of Measles Vaccine therapy.The symptomatic adverse reactions produced by Measles Vaccine are more or less tolerable and if they become severe, they can be treated symptomatically, these include Headache, Vomiting, Fever, Skin rashes, Rashes, Pruritus, Redness, Malaise, Cough, Edema, Purpura, Coryza, Hemiplegia, Vesiculation, Skin rashes.
Indications
Measles Vaccine is primarily indicated in conditions like Measles prevention.
Interactions
Measles Vaccine is known to interact with other drugs, the details of drug interactions is as follows:DrugDetailsSeverityOnsetManagementRabies Immune Globulin Measles Vaccinemay have delayed or diminished antibody response with immune globulin administration. Should not be administered within 3 months unless antibody titers dictate as appropriate.Rho (D) Immune Globulin Antibodies found in immune globulins may interfere with the immune response to live vaccines.ModerateVaricella vaccine should not be given for at least 5 months after, and other live vaccines should not be given for at least 3 months after administration of immune globulin.RituximabThe administration of live, attenuated virus or bacterial vaccines during immunosuppressant or intense antineoplastic therapy may be associated with a risk of disseminated infection due to enhanced replication of vaccine virus or bacteria in the presence of diminished immune competence.MajorThe administration of live, attenuated virus or bacterial vaccines during immunosuppressant or intense antineoplastic therapy may be associated with a risk of disseminated infection due to enhanced replication of vaccine virus or bacteria in the presence of diminished immune competence. These interactions are sometimes beneficial and sometimes may pose threats to life. Always consult your physician for the change of dose regimen or an alternative drug of choice that may strictly be required.
Interfrence
Risks
Drug should not be given to Pregnant Mothers.If prescribing authority justifies the benefits of the drug against the possible damages he/she should reevaluate them and consult the reference material and previous studies.
Storage
Inj Store in refrigerator. Do not Freeze. Protect from Sunlight.
Warnings
It should be used with caution in children with a history of febrile seizures and cerebral injury. Caution in patients with a history of anaphylactic reactions to eggs or a neomycin allergy. Avoid use of measles vaccine in immunocompromised patients, defer administration in presence of acute respiratory or other active infections or inactive, untreated tuberclosis, avoid pregnancy for three months following vaccination, hypersensitivity reactions may occur.
Back to List

Any information that appears on this website page is provided for the purpose of general information. This website has been compiled in good faith by HMIS.Online. However, no guarantee is made as to the completeness, validity or accuracy of the information it contains.